Business Description
Medicover AB
ISIN : SE0009778848
Share Class Description:
FRA:5M0B: Class BTotal Employee Number:
49,000Compare
Compare
Traded in other countries / regions
MCOV B.Sweden0RPS.UK5M0B.GermanyMCVEY.USA IPO Date
2017-05-24Description
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.23 | |||||
Debt-to-Equity | 2.6 | |||||
Debt-to-EBITDA | 3.64 | |||||
Interest Coverage | 2.54 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.25 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 15.4 | |||||
3-Year EBITDA Growth Rate | 19.5 | |||||
3-Year EPS without NRI Growth Rate | 70.7 | |||||
3-Year FCF Growth Rate | 82.9 | |||||
3-Year Book Growth Rate | 3.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 31.39 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.97 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 31.3 | |||||
9-Day RSI | 40.05 | |||||
14-Day RSI | 45.52 | |||||
3-1 Month Momentum % | 2.69 | |||||
6-1 Month Momentum % | -1.95 | |||||
12-1 Month Momentum % | -16.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.74 | |||||
Quick Ratio | 0.65 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 12.34 | |||||
Days Sales Outstanding | 46.72 | |||||
Days Payable | 46.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.97 | |||||
Dividend Payout Ratio | 0.29 | |||||
3-Year Dividend Growth Rate | 7.4 | |||||
Forward Dividend Yield % | 0.97 | |||||
5-Year Yield-on-Cost % | 1 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | -5.51 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 23.32 | |||||
Operating Margin % | 6.86 | |||||
Net Margin % | 3.28 | |||||
EBITDA Margin % | 15.91 | |||||
FCF Margin % | 7.13 | |||||
OCF Margin % | 13.57 | |||||
ROE % | 15.62 | |||||
ROA % | 3.4 | |||||
ROIC % | 5.57 | |||||
3-Year ROIIC % | 10.66 | |||||
ROC (Joel Greenblatt) % | 15.73 | |||||
ROCE % | 9.7 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 38.76 | |||||
Forward PE Ratio | 29.68 | |||||
PE Ratio without NRI | 38.76 | |||||
Shiller PE Ratio | 79.04 | |||||
Price-to-Owner-Earnings | 18.39 | |||||
PEG Ratio | 2.47 | |||||
PS Ratio | 1.27 | |||||
PB Ratio | 5.7 | |||||
Price-to-Free-Cash-Flow | 17.84 | |||||
Price-to-Operating-Cash-Flow | 9.37 | |||||
EV-to-EBIT | 26.78 | |||||
EV-to-Forward-EBIT | 28.25 | |||||
EV-to-EBITDA | 11.55 | |||||
EV-to-Forward-EBITDA | 9.68 | |||||
EV-to-Revenue | 1.84 | |||||
EV-to-Forward-Revenue | 1.41 | |||||
EV-to-FCF | 25.77 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 1.49 | |||||
Price-to-DCF (Earnings Based) | 1.12 | |||||
Price-to-DCF (FCF Based) | 0.48 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.11 | |||||
Earnings Yield (Greenblatt) % | 3.73 | |||||
FCF Yield % | 5.62 | |||||
Forward Rate of Return (Yacktman) % | 16.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicover AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,424.2 | ||
| EPS (TTM) (€) | 0.526 | ||
| Beta | 1.1256 | ||
| 3-Year Sharpe Ratio | 0.5 | ||
| 3-Year Sortino Ratio | 0.85 | ||
| Volatility % | 29.46 | ||
| 14-Day RSI | 45.52 | ||
| 14-Day ATR (€) | 0.398747 | ||
| 20-Day SMA (€) | 20.403 | ||
| 12-1 Month Momentum % | -16.32 | ||
| 52-Week Range (€) | 16.74 - 25.35 | ||
| Shares Outstanding (Mil) | 150.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicover AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicover AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-29 | In 103 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 103 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-22 | In 4 days | ||
| Second quarter earnings results for 2026 | 2026-07-22 | In 4 days | ||
| EUR 0.200000 Cash Dividend | 2026-04-30 | 18.18 (+3.30%) | ||
| General meeting for 2026 | 2026-04-29 13:00 | 18.02 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-29 09:30 | 18.02 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 07:45 | 18.02 (+0.00%) | ||
| Annual report for 2025 | 2026-03-30 | 17.08 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-10 09:30 | 19.02 (+0.00%) |
Show
Entries
Medicover AB Frequently Asked Questions
What is Medicover AB(FRA:5M0B)'s stock price today?
The current price of FRA:5M0B is €19.72. The 52 week high of FRA:5M0B is €25.35 and 52 week low is €16.74.
When is next earnings date of Medicover AB(FRA:5M0B)?
The next earnings date of Medicover AB(FRA:5M0B) is 2026-07-22.
Does Medicover AB(FRA:5M0B) pay dividends? If so, how much?
The Dividend Yield %  of Medicover AB(FRA:5M0B) is 0.97% (As of Today), Highest Dividend Payout Ratio of Medicover AB(FRA:5M0B) was 1.58. The lowest was 0.1. And the median was 0.63. The  Forward Dividend Yield % of Medicover AB(FRA:5M0B) is 0.97%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medicover AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers